1. Adams, DH, Howie, AJ, Michael, J, McConkey, B, Bacon, PA & Adu, D (1986). Non-steroidal anti-inflammatory drugs and renal failure. Lancet 1: 57–60.
2. Antiplatelet Trialists’ Collaboration (1994). Collaborative overview of randomised trials of antiplatelet therapy. I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308: 81–106.
3. Armstrong, B, Garrod, A & Doll, R (1976). A retrospective study of renal cancer with special reference to coffee and animal protein consumption. Br J Cancer 33: 127–136.
4. Asal, NR, Geyer, JR, Risser, DR, Lee, ET, Kadamani, S & Cherng, N (1988). Risk factors in renal cell carcinoma. II. Medical history, occupation, multivariate analysis, and conclusions. Cancer Detect Prev 13: 263–279.
5. Bengtsson, U, Angervall, L, Ekman, H & Lehmann, L (1968). Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 2: 145–150.